Paragraph 60 Release of information by the marketing authorisation holder

A marketing authorisation holder must not communicate information relating to pharmacovigilance concerns to F1veterinary surgeons or the general public in relation to its authorised veterinary medicinal product without giving prior or simultaneous notification to the Secretary of State.

The marketing authorisation holder must ensure that such information is presented objectively and is not misleading.

For the purposes of this paragraph “information” includes any information contained in advertising material.